Clinical pharmacology studies
Ended Awarded Last action
- Contract number
- 75F40123F19005
- Awardee
-
Spaulding Clinical Research, LLC UEI HERBKHMPKQN5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $6,000,321
Award facts
- Contract value 100% obligated
- $6,000,320.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- West Bend, WI 53095, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $1,000,264 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $5,000,057 |
About this award
The U.S. Food and Drug Administration (FDA) awarded a $6,000,320.69 firm fixed price delivery order contract to Spaulding Clinical Research, LLC, a self-certified small disadvantaged business, for-profit organization, and limited liability company. The contract is for clinical pharmacology studies to support the FDA's regulatory science programs and assist in regulatory decision-making across product lifecycles. Spaulding Clinical Research performs this work at its facilities in West Bend, Wisconsin and Silver Spring, Maryland. The delivery order is part of a larger $30 million single award Indefinite Delivery Indefinite Quantity (IDIQ) contract awarded to Spaulding Clinical Research in 2019 to provide clinical and laboratory applied regulatory science services to the FDA. The contract has a performance period through March 28, 2026.
Quick answers
Who was awarded contract 75F40123F19005?
75F40123F19005 was awarded to Spaulding Clinical Research, LLC by Food and Drug Administration (Department of Health and Human Services) on September 28, 2023.
How much is contract 75F40123F19005 worth?
The government has obligated $6,000,321 on 75F40123F19005.
Is contract 75F40123F19005 an order under another contract?
Yes. 75F40123F19005 is a delivery order under 75F40119D10032, an indefinite delivery contract.
Was contract 75F40123F19005 competed?
The extent of competition for 75F40123F19005 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award